Search

Search Results

• Development of LY2334737, an oral gemcitabine prodrug for continuous administration. Perspectives for the therapy of mature T-cell and NK-cell lymphomas

  O Shonukan, AH Dantzig, S Kloeker-Rhoades, I Garcia-Ribas

  2009-06-11

  Published: June 11, 2009

  293

  PDF: 404